These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36094793)

  • 1. Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings.
    Galosi E; Leonardi L; Falco P; Di Pietro G; Fasolino A; Esposito N; Leone C; Di Stefano G; Inghilleri M; Luigetti M; Giovanni A; Truini A
    Amyloid; 2023 Mar; 30(1):59-66. PubMed ID: 36094793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN).
    Galosi E; Costanzo R; Forcina F; Morino S; Antonini G; Salvetti M; Lauletta A; Luigetti M; Romano A; Primiano G; Guglielmino V; Fionda L; Garibaldi M; Esposito N; Falco P; di Pietro G; Truini A; Leonardi L
    Neurol Sci; 2024 Oct; 45(10):5023-5032. PubMed ID: 38700599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative sensory testing and skin biopsy findings in late-onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO).
    Leonardi L; Costanzo R; Forcina F; Morino S; Antonini G; Salvetti M; Luigetti M; Romano A; Primiano G; Guglielmino V; Fionda L; Garibaldi M; Lauletta A; Rossini E; Tufano L; Ceccanti M; Esposito N; Falco P; di Pietro G; Truini A; Galosi E
    J Peripher Nerv Syst; 2023 Sep; 28(3):390-397. PubMed ID: 37535421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.
    Pasutharnchat N; Taychargumpoo C; Vorasettakarnkij Y; Amornvit J
    BMC Neurol; 2021 May; 21(1):206. PubMed ID: 34022837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis.
    Leonardi L; Adam C; Beaudonnet G; Beauvais D; Cauquil C; Not A; Morassi O; Benmalek A; Trassard O; Echaniz-Laguna A; Adams D; Labeyrie C
    Eur J Neurol; 2022 May; 29(5):1477-1487. PubMed ID: 35100482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.
    Kleefeld F; Scherret E; Knebel F; Messroghli D; Heidecker B; Wetz C; Schatka I; Barzen G; Tschöpe C; Amthauer H; Hahn K
    Amyloid; 2022 Jun; 29(2):92-101. PubMed ID: 34994254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays.
    Kaku MC; Bhadola S; Berk JL; Sanchorawala V; Connors LH; Lau KHV
    Amyloid; 2022 Sep; 29(3):184-189. PubMed ID: 35253562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
    Lin X; Yarlas A; Vera-Llonch M; Baranwal N; Biber J; Brown D; Vogt B; Karam C
    BMC Neurol; 2021 Feb; 21(1):70. PubMed ID: 33579211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis.
    Thimm A; Carpinteiro A; Oubari S; Papathanasiou M; Kessler L; Rischpler C; Malik RA; Herrmann K; Reinhardt HC; Rassaf T; Kleinschnitz C; Hagenacker T; Stettner M
    J Neurol; 2023 Jul; 270(7):3483-3491. PubMed ID: 37014422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis.
    Carroll AS; Park SB; Lin CSY; Taylor MS; Kwok F; Simon NG; Reilly MM; Kiernan MC; Vucic S
    Clin Neurophysiol; 2024 Mar; 159():81-95. PubMed ID: 38377648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between a commercial electrophysiological test of sudomotor function and intraepidermal nerve fiber density in hereditary transthyretin amyloidosis.
    Masuda T; Misumi Y; Nomura T; Yamakawa S; Tasaki M; Obayashi K; Ando Y; Ueda M
    Muscle Nerve; 2024 Jan; 69(1):99-102. PubMed ID: 37960924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic screening for hereditary transthyretin amyloidosis with polyneuropathy in western Sicily: Two years of experience in a neurological clinic.
    Di Stefano V; Lupica A; Alonge P; Pignolo A; Augello SM; Gentile F; Gagliardo A; Giglia F; Brinch D; Cappello M; Di Lisi D; Novo G; Borgione E; Scuderi C; Brighina F
    Eur J Neurol; 2024 Jan; 31(1):e16065. PubMed ID: 37725003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes of nerve integrity in preclinical carriers of hereditary transthyretin Ala117Ser amyloidosis with polyneuropathy.
    Chiang MC; Yeh TY; Sung JY; Hsueh HW; Kao YH; Hsueh SJ; Chang KC; Feng FP; Lin YH; Chao CC; Hsieh ST
    Eur J Neurol; 2021 Mar; 28(3):982-991. PubMed ID: 33369810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy.
    Leonardi L; Vanoli F; Fionda L; Loreti S; Garibaldi M; Morino S; Salvetti M; Russo D; Musumeci B; Antonini G
    Neurol Sci; 2020 Dec; 41(12):3775-3778. PubMed ID: 32936357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation.
    Leonardi L; Galosi E; Vanoli F; Fasolino A; Di Pietro G; Luigetti M; Sabatelli M; Fionda L; Garibaldi M; Alfieri G; Lauletta A; Morino S; Salvetti M; Truini A; Antonini G
    Neurol Sci; 2022 Feb; 43(2):1359-1364. PubMed ID: 34189665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts.
    Karam C; Mauermann ML; Gonzalez-Duarte A; Kaku MC; Ajroud-Driss S; Brannagan TH; Polydefkis M
    Muscle Nerve; 2024 Mar; 69(3):273-287. PubMed ID: 38174864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.
    Ungerer MN; Hund E; Purrucker JC; Huber L; Kimmich C; Aus dem Siepen F; Hein S; Kristen AV; Hinderhofer K; Kollmer J; Schönland S; Hegenbart U; Weiler M
    Amyloid; 2021 Jun; 28(2):91-99. PubMed ID: 33283548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red flags and adjusted suspicion index for distinguishing hereditary transthyretin amyloid polyneuropathy from idiopathic axonal polyneuropathy.
    Warendorf JK; van der Star GM; Dooijes D; Notermans NC; Vrancken AFJE
    Neurol Sci; 2023 Oct; 44(10):3679-3685. PubMed ID: 37266816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
    Adams D; Ando Y; Beirão JM; Coelho T; Gertz MA; Gillmore JD; Hawkins PN; Lousada I; Suhr OB; Merlini G
    J Neurol; 2021 Jun; 268(6):2109-2122. PubMed ID: 31907599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type.
    Papagianni A; Ihne S; Zeller D; Morbach C; Üçeyler N; Sommer C
    Amyloid; 2022 Mar; 29(1):14-22. PubMed ID: 34632904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.